Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways
Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. It has many types, the
Papillary thyroid cancer (PTC)(most common and follicular thyroid carcinoma (FTC). Several …
Papillary thyroid cancer (PTC)(most common and follicular thyroid carcinoma (FTC). Several …
[HTML][HTML] Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis
Background Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies
arising from the epithelium of the head and neck. Despite efforts in treatment, results have …
arising from the epithelium of the head and neck. Despite efforts in treatment, results have …
[HTML][HTML] Long non‑coding RNA DSCAM‑AS1 functions as an oncogene in thyroid cancer via regulating miR‑211
T Hua, J Yang, Y Zhu, Y Luo - Oncology Letters, 2023 - spandidos-publications.com
Long non‑coding RNA Down syndrome cell adhesion molecule‑antisense 1 (DSCAM‑AS1)
has been reported to play key roles in the progression and initiation of several cancer types …
has been reported to play key roles in the progression and initiation of several cancer types …
[HTML][HTML] MicroRNA Expression Profiling—Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes
H Silaghi, LA Pop, CE Georgescu, D Muntean… - Biomedicines, 2024 - mdpi.com
Recent research has revealed the importance of miRNAs in the diagnosis and clinical
evolution of papillary thyroid cancer (PTC). We aim to identify a specific miRNA profile that …
evolution of papillary thyroid cancer (PTC). We aim to identify a specific miRNA profile that …
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer
J Buscombe - Seminars in Nuclear Medicine, 2023 - Elsevier
The use of radioiodine (I-131) in the management of patients suffering differentiated thyroid
cancer (DTC) has changed little in the past 40 years. The use of a standardized approach …
cancer (DTC) has changed little in the past 40 years. The use of a standardized approach …
[HTML][HTML] Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
B Xu, SY Gu, NM Zhou, JJ Jiang - Open Life Sciences, 2023 - degruyter.com
High thyroid stimulating hormone (TSH) levels may stimulate papillary thyroid cancer (PTC)
cell proliferation; however, the relationship between TSH levels and PTC risk remains …
cell proliferation; however, the relationship between TSH levels and PTC risk remains …
Analysis of plasma exosomal miRNAs in papillary thyroid carcinoma with or without lymph node metastasis
X Cao, Q He - 2023 - researchsquare.com
Objective: Lymph node metastasis (LNM) is one of the difficulties in the treatment of papillary
thyroid carcinoma (PTC). To improve the early detection of PTC LNM and search for novel …
thyroid carcinoma (PTC). To improve the early detection of PTC LNM and search for novel …
[PDF][PDF] Обґрунтування органозберігаючої тактики хірургічного лікування папілярного раку щитоподібної залози
ДМ Квітка - 2023 - ir.librarynmu.com
Квітка Дмитро Миколайович ДИСЕРТАЦІЯ Page 1 МІНІСТЕРСТВО ОХОРОНИ ЗДОРОВ’Я
УКРАЇНИ НАЦІОНАЛЬНИЙ МЕДИЧНИЙ УНІВЕРСИТЕТ ІМЕНІ ООБОГОМОЛЬЦЯ …
УКРАЇНИ НАЦІОНАЛЬНИЙ МЕДИЧНИЙ УНІВЕРСИТЕТ ІМЕНІ ООБОГОМОЛЬЦЯ …